Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Gaenzle Christopher L

2. Date of Event Requiring Statement (MM/DD/YYYY) 2/24/2020

3. Issuer Name and Ticker or Trading Symbol

PRA Health Sciences, Inc. [PRAH]

(Last) (First) (Middle)

C/O PRA HEALTH SCIENCES, INC., 4130 PARKLAKE AVENUE, SUITE 400

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
EVP, Chief Admin Officer & GC /

(Street)

RALEIGH, NC 27612

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common stock	39000 ⁽¹⁾	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽²⁾	8/10/2028	Common stock	75000	$101.42	D
Stock Option (Right to Buy)	⁽³⁾	8/13/2029	Common stock	25000	$95.94	D

Explanation of Responses:
(1)	Represents (a) 30,000 shares of restricted stock granted on August 10, 2018 under the issuer's 2018 Stock Incentive Plan (the "Plan"), all of which will vest on August 10, 2021, subject to the holder's continued service through such date, and (b) 9,000 shares of restricted stock granted on August 13, 2019 under the Plan, half of which will vest on August 13, 2020 and half of which will vest on August 13, 2021, subject to the holder's continued service through such dates.
(2)	The options were granted on August 10, 2018 under the Plan. 18,750 options vested on August 10, 2019 and 18,750 options will vest on each of August 10, 2020, August 10, 2021 and August 10, 2022, subject to the holder's continued service through such dates.
(3)	The options were granted on August 13, 2019 under the Plan and vest one-third per year on each anniversary of the grant date, subject to the holder's continued service through such dates.

Remarks:
Exhibit 24.1 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Gaenzle Christopher L C/O PRA HEALTH SCIENCES, INC. 4130 PARKLAKE AVENUE, SUITE 400 RALEIGH, NC 27612			EVP, Chief Admin Officer & GC